← All organizations
Highest phase reached
Phase 4
First clinical trial
Aug 1, 2007Last known activity
Jan 31, 2027
Timeline
1970s
- Jun 1, 1972
Eurofarma Laboratorios S.A.— Founded
Drugs by trial phase (60 distinct, 52 trials)
Phase 4 (1 own, 0 via acquisition)
Phase 3 (57 own, 0 via acquisition)
Phase 2 (1 own, 0 via acquisition)
Other trials (1 own, 0 via acquisition)
Indications
Studied for
- Acute Coronary Syndrome
- Adenocarcinoma
- Angina, Unstable
- Asthma
- Breast Neoplasms
- Carcinoma
- Carcinoma, Adenosquamous
- Carcinoma, Non-Small-Cell Lung
- Cystitis
- Diabetes Mellitus
- Diabetes Mellitus, Type 2
- Esophageal Neoplasms
- Esophagitis, Peptic
- Fractures, Bone
- Gastroesophageal Reflux
- Glioma
- Heart Failure
- Hip Fractures
- Hypertension
- Infarction
- Lactose Intolerance
- Low Back Pain
- Lung Neoplasms
- Migraine Disorders
- Myocardial Infarction
- Neutropenia
- Osteoarthritis
- Osteoarthritis, Knee
- Prostatic Neoplasms
- Rhinitis
- Rhinitis, Allergic
- Rhinitis, Allergic, Perennial
- Sleep Initiation and Maintenance Disorders
Recent trials (50)
- NCT07303322Lead sponsorPhase 3Jan 31, 2027
- NCT06546735Lead sponsorPhase 3Nov 30, 2026
- NCT06560333Lead sponsorPhase 3Nov 30, 2026
- NCT07057479Lead sponsorPhase 3Sep 30, 2026
- NCT06234345Lead sponsorPhase 3Feb 28, 2026
- NCT06715462Lead sponsorPhase 3Nov 30, 2025
- NCT07018557CollaboratorPhase 4Jun 4, 2025
- NCT05209984Lead sponsorPhase 3Jun 30, 2024
- NCT05683574Lead sponsorPhase 3Jun 30, 2024
- NCT05214911Lead sponsorPhase 3Oct 1, 2023
- NCT05081102Lead sponsorPhase 3Feb 28, 2023
- NCT05118672Lead sponsorPhase 3Aug 17, 2022
- NCT04972292Lead sponsorPhase 3Jul 31, 2022
- NCT04721548Lead sponsorPhase 3Dec 30, 2021
- NCT04384367Lead sponsorPhase 3Feb 28, 2021
Details
- Founded
- Sao Paulo, BR Jun 1, 1972
- Last known activity
- Jan 31, 2027